SCHEMBL21248402

SCHEMBL21248402

CC1CCN(C(=O)c2cnn3ccc(C4CCN(C(=O)OC(C)(C)C)CC4)cc23)CC1

nearest known ligand 0.57

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.57
▸ TP53 P04637 3/20 0.49
▸ THRB P10828 1/20 0.49
▸ POLB P06746 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21247887 0.93 TP53 (0.56) TP53POLB
SCHEMBL21247862 0.92 TP53 (0.57) TP53POLB
SCHEMBL21248018 0.92 TP53 (0.57) TP53POLB
SCHEMBL21248283 0.92 LMNA (0.48) LMNATP53THRB
SCHEMBL21263008 0.88 MEN1 (0.54) TP53THRBPOLB
SCHEMBL21247961 0.86 TP53 (0.47) TP53THRBPOLB
SCHEMBL21248566 0.85 LMNA (0.48) LMNATP53POLB
SCHEMBL21248037 0.83 TP53 (0.44) LMNATP53THRBPOLB
SCHEMBL21248297 0.83 FASN (0.50) —
SCHEMBL23483838 0.82 FASN (0.50) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12077508-B2 Inhibitors of the Notch transcriptional activation complex kinase (“NACK”) and methods for use of the same UNIVERSITY OF MIAMI (US) 2024-09-03 — — US disclosed
EP-3749355-B1 INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX KINASE (\"NACK\") AND METHODS FOR USE OF THE SAME UNIV MIAMI (US) 2024-07-03 — — EP disclosed
US-11649214-B2 Inhibitors of the notch transcriptional activation complex kinase (“NACK”) and methods for use of the same UNIVERSITY OF MIAMI (US) 2023-05-16 — — US disclosed
US-20230113546-A1 INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX KINASE (\"NACK\") AND METHODS FOR USE OF THE SAME UNIVERSITY OF MIAMI 2023-04-13 — — US disclosed
US-20210171469-A1 INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX KINASE (\"NACK\") AND METHODS FOR USE OF THE SAME UNIVERSITY OF MIAMI 2021-06-10 — — US disclosed
EP-3749355-A1 INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX KINASE (\"NACK\") AND METHODS FOR USE OF THE SAME University of Miami (US) 2020-12-16 — — EP disclosed
WO-2019157065-A9 INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX KINASE (\"NACK\") AND METHODS FOR USE OF THE SAME UNIVERSITY OF MIAMI (US) 2020-10-29 — — WO disclosed
WO-2019157065-A1 INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX KINASE (\"NACK\") AND METHODS FOR USE OF THE SAME UNIVERSITY OF MIAMI (US) 2019-08-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210171469-A1 INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX KINASE (\"NACK\") AND METHODS FOR USE OF THE SAME CHUK, NOTCH1, NUAK1 LMNA 3177/4885TP53 439/4885THRB 1484/4885
US-20230113546-A1 INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX KINASE (\"NACK\") AND METHODS FOR USE OF THE SAME CHUK, NUAK1, NOTCH1 LMNA 2887/4885TP53 548/4885THRB 1433/4885
US-11649214-B2 Inhibitors of the notch transcriptional activation complex kinase (“NACK”) and methods for use of the same NOTCH1, CHUK, CBFB LMNA 3280/4885TP53 495/4885THRB 1680/4885
US-12077508-B2 Inhibitors of the Notch transcriptional activation complex kinase (“NACK”) and methods for use of the same NOTCH1, CHUK, NUAK1 LMNA 2959/4885TP53 518/4885THRB 1648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback